Since the glycolytic beige fat has been emphasized in promoting energy metabolism and thermogenesis [20], regulating glycolysis in AT via targeting PGAM2 could be a potential approach for obesity treatment. This evidence concerns the gene PGAM2 and obesity due to melanocortin 4 receptor deficiency.